The present study aimed to determine whether
Nicotiflorin, a natural
flavonoid extracted from coronal of Carthamus tinctorius, has a protective effect on cerebral
multi-infarct dementia in rats. The
multi-infarct dementia model rats were prepared by injecting man-made micro-thrombi into the right hemisphere. The administration groups were treated once daily with 30, 60 and 120 mg/kg
Nicotiflorin (i.g.) from 5 days before
ischemia operation to 3 days after the operation for biochemical examination, 10 days for Morris water maze study and morphological observations and 20 days for eight-arm radial maze task.
2,3,5-triphenyltetrazolium chloride (TTC) staining showed that
infarct volume of each
Nicotiflorin administration group was much smaller than that of vehicle-treated
multi-infarct dementia group, and
hematoxylin and
eosin (HE) staining showed that histopathological abnormalities of each
Nicotiflorin group were also much lighter than that of vehicle-treated
multi-infarct dementia group. Each
Nicotiflorin group showed much better spatial memory performance in Morris water maze tests and eight-arm radial maze task compared with the vehicle-treated
multi-infarct dementia group, significantly attenuated the elevation of
lactic acid and
malondialdehyde (MDA) contents and the decrease in
lactate dehydrogenase (LDH), Na(+)K(+)
ATPase,
Ca(2+)Mg(2+)ATPase and
superoxide dismutase (SOD) activity in the brain tissue which was composed of striatum, cortex and hippocampus of the
ischemia hemisphere at day 3 after
ischemia operation. These results suggest that
Nicotiflorin has protective effects on reducing memory dysfunction, energy metabolism failure and oxidative stress in
multi-infarct dementia model rats.